PALIGEN

Serial Number 85032602
606

Registration Progress

Application Filed
May 7, 2010
Under Examination
Dec 7, 2010
Approved for Publication
Sep 22, 2010
Published for Opposition
Oct 12, 2010
Registered

Basic Information

Serial Number
85032602
Filing Date
May 7, 2010
Published for Opposition
October 12, 2010
Abandonment Date
January 13, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 13, 2014
Classes
005 042

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
3rd Floor
300 3rd Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Ann Lamport Hammitte

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description
Jan 13, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jan 13, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 21, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
May 20, 2013 EX5G S SOU EXTENSION 5 GRANTED
May 9, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
May 9, 2013 EXT5 S SOU EXTENSION 5 FILED
Nov 14, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Nov 13, 2012 EX4G S SOU EXTENSION 4 GRANTED
Nov 9, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 9, 2012 EXT4 S SOU EXTENSION 4 FILED
Jun 6, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jun 5, 2012 EX3G S SOU EXTENSION 3 GRANTED
Jun 1, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 1, 2012 EXT3 S SOU EXTENSION 3 FILED
Dec 13, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Dec 12, 2011 EX2G S SOU EXTENSION 2 GRANTED
Dec 6, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 6, 2011 EXT2 S SOU EXTENSION 2 FILED
Mar 31, 2011 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Mar 30, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 30, 2011 EX1G S SOU EXTENSION 1 GRANTED
Mar 21, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 21, 2011 EXT1 S SOU EXTENSION 1 FILED
Dec 7, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 12, 2010 PUBO A PUBLISHED FOR OPPOSITION
Sep 22, 2010 NPUB O NOTICE OF PUBLICATION
Sep 4, 2010 ALIE A ASSIGNED TO LIE
Sep 4, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 23, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2010 DOCK D ASSIGNED TO EXAMINER
May 13, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2010 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
a full line of pharmaceuticals, biosimilars and biological preparations for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
scientific research; scientific research in the field of stem cells for research or scientific purposes
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042